| TTM
|
10/31/2025
|
10/31/2024
|
10/31/2023
|
10/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
|
-109.1160 | -84.3870 | -31.4630 | -23.0270 | -24.0690 |
|
Gross Profit
|
-109.1160 | -84.3870 | -31.4630 | -23.0270 | -24.0690 |
| Selling, General and Administrative Expenses
|
-2,502.7920 | -1,991.2060 | -1,430.3490 | -1,484.4440 | -2,010.2040 |
|
Research and Development Expenses
|
-157.8000 | -167.9380 | -126.5030 | -101.9670 | -79.7740 |
|
Accretion of Asset Retirement Obligation
|
-131.7700 | -128.8720 | -125.1210 | -105.0280 | -40.8020 |
| Other Income/Expense, Operating
|
-801.2490 | -822.8470 | -705.2050 | -534.2840 | -550.6020 |
|
Operating Income/Expenses
|
-3,593.6110 | -3,110.8630 | -2,387.1780 | -2,225.7230 | -2,681.3820 |
|
Total Operating Profit/Loss
|
-3,702.7270 | -3,195.2500 | -2,418.6410 | -2,248.7500 | -2,705.4510 |
| Total Net Finance Income/Expense
|
22.8740 | 55.3360 | 97.3750 | 61.4920 | 25.4970 |
| Net Investment Income
|
-89.0270 | -79.3100 | -201.1950 | -135.9040 | -490.1740 |
| Irregular Income/Expenses
|
0 | 0 | -165.6690 | -81.1170 | 0 |
|
Other Income/Expense, Non-Operating
|
26.2220 | 2.6590 | 0.4060 | 7.1720 | 6.5710 |
|
Non-Operating Income/Expenses, Total
|
-39.9310 | -21.3150 | -269.0830 | -148.3570 | -458.1060 |
|
Pretax Income
|
-3,742.6580 | -3,216.5650 | -2,687.7240 | -2,397.1070 | -3,163.5570 |
|
Net Income from Continuing Operations
|
-3,742.6580 | -3,216.5650 | -2,687.7240 | -2,397.1070 | -3,163.5570 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-3,742.6580 | -3,216.5650 | -2,687.7240 | -2,397.1070 | -3,163.5570 |
|
Net Income after Non-Controlling/Minority Interests
|
-3,742.6580 | -3,216.5650 | -2,687.7240 | -2,397.1070 | -3,163.5570 |
|
Net Income Available to Common Stockholders
|
-3,742.6580 | -3,216.5650 | -2,687.7240 | -2,397.1070 | -3,163.5570 |
|
Diluted Net Income Available to Common Stockholders
|
-3,742.6580 | -3,216.5650 | -2,687.7240 | -2,397.1070 | -3,163.5570 |
| Basic EPS
|
-0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Diluted EPS
|
-0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
|
Basic Weighted Average Shares Outstanding
|
252,770.1790 | 236,526.5900 | 200,413.8930 | 167,139.9710 | 151,801.7340 |
|
Diluted Weighted Average Shares Outstanding
|
252,770.1790 | 236,526.5900 | 200,413.8930 | 167,139.9710 | 151,801.7340 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-3,765.5320 | -3,271.9010 | -2,785.0990 | -2,458.5990 | -3,189.0540 |
|
EBITDA
|
-3,656.4160 | -3,187.5140 | -2,753.6360 | -2,435.5720 | -3,164.9850 |
|
Normalized EBITDA
|
-2,212.2240 | -2,069.1830 | -1,671.2170 | -1,495.2160 | -1,608.7200 |
|
Normalized Income
|
-2,298.4660 | -3,195.2500 | -2,418.6410 | -2,248.7500 | -2,705.4510 |
|
Total Unusual Items
|
1,444.1920 | 1,118.3310 | 1,082.4190 | 940.3560 | 1,556.2650 |
10/31/2022 - 1/22/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade